5 research outputs found
Comprehensive SNP Scan of DNA Repair and DNA Damage Response Genes Reveal Multiple Susceptibility Loci Conferring Risk to Tobacco Associated Leukoplakia and Oral Cancer
Polymorphic variants of DNA repair and damage response genes play major role in carcinogenesis. These variants are
suspected as predisposition factors to Oral Squamous Cell Carcinoma (OSCC). For identification of susceptible variants
affecting OSCC development in Indian population, the ‘‘maximally informative’’ method of SNP selection from HapMap data
to non-HapMap populations was applied. Three hundred twenty-five SNPs from 11 key genes involved in double strand
break repair, mismatch repair and DNA damage response pathways were genotyped on a total of 373 OSCC, 253
leukoplakia and 535 unrelated control individuals. The significantly associated SNPs were validated in an additional cohort
of 144 OSCC patients and 160 controls. The rs12515548 of MSH3 showed significant association with OSCC both in the
discovery and validation phases (discovery P-value: 1.43E-05, replication P-value: 4.84E-03). Two SNPs (rs12360870 of
MRE11A, P-value: 2.37E-07 and rs7003908 of PRKDC, P-value: 7.99E-05) were found to be significantly associated only with
leukoplakia. Stratification of subjects based on amount of tobacco consumption identified SNPs that were associated with
either high or low tobacco exposed group. The study reveals a synergism between associated SNPs and lifestyle factors in
predisposition to OSCC and leukoplakia
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.
To identify colorectal cancer (CRC) susceptibility alleles, we conducted a genome-wide association study. In phase 1, we genotyped 550,163 tagSNPs in 940 familial colorectal tumor cases (627 CRC, 313 high-risk adenoma) and 965 controls. In phase 2, we genotyped 42,708 selected SNPs in 2,873 CRC cases and 2,871 controls. In phase 3, we evaluated 11 SNPs showing association at P < 10(-4) in a joint analysis of phases 1 and 2 in 4,287 CRC cases and 3,743 controls. Two SNPs were taken forward to phase 4 genotyping ( 10,731 CRC cases and 10,961 controls from eight centers). In addition to the previously reported 8q24, 15q13 and 18q21 CRC risk loci, we identified two previously unreported associations: rs10795668, located at 10p14 (P=2.5 x 10(-13) overall; P=6.9 x 10(-12) replication), and rs16892766, at 8q23.3 (P=3.3 x 10(-18) overall; P=9.6 x 10(-17) replication), which tags a plausible causative gene, EIF3H. These data provide further evidence for the 'common-disease common-variant' model of CRC predispositio